Stuart Bryan's Form 4 filing
Fulcrum Therapeutics, Inc. (FULC) · filed Aug 12, 2021
- Accession no.
- 0000899243-21-032753
- Filed
- Aug 12, 2021
- Trade date
- Aug 10-11, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.23M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Stuart BryanCIK 0001619846 | Director, Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2021 | Common Stock | MOption exerciseAcquired | +32,000 | $7.84 | +$250,880 | 32,000 | Direct | |
| Aug 10, 2021 | Common Stock | SSaleDisposed | −32,000 | $17.50 | −$560,000 | 0 | Direct | |
| Aug 11, 2021 | Common Stock | MOption exerciseAcquired | +28,000 | $7.84 | +$219,520 | 28,000 | Direct | |
| Aug 11, 2021 | Common Stock | SSaleDisposed | −28,000 | $23.75 | −$665,000 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2021 | Common Stock | MOption exerciseDisposed | −32,000 | $0.00 | $0 | 271,571 | Direct | |
| Aug 11, 2021 | Common Stock | MOption exerciseDisposed | −28,000 | $0.00 | $0 | 243,571 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.